Listen "Inflammation in Obesity-Related HFpEF: The STEP-HFpEF Program"
Episode Synopsis
In this episode, Dr. Valentin Fuster discusses a pivotal study on inflammation's role in obesity-related heart failure with preserved ejection fraction, highlighting findings from the STEP heart failure program. The research reveals that semaglutide improves heart failure symptoms and reduces inflammation across varying baseline CRP levels, suggesting cardiovascular benefits that extend beyond weight loss alone.
More episodes of the podcast JACC This Week
December 2, 2025: Global CVD 1990–2023: Trends, Risks, and the Road Ahead | JACC This Week
24/11/2025
November 18, 2025: Adiposity, Heart Failure, and the Future of Cardiometabolic Care | JACC This Week
10/11/2025
November 11, 2025: Precision, Place, and the Future of Cardiovascular Prediction | JACC This Week
03/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.